Fig. 1From: High SLFN11 expression predicts better survival for patients with KRAS exon 2 wild type colorectal cancer after treated with adjuvant oxaliplatin-based treatmentThe typical staining of intensity: 0, none; 1, weak; 2: moderate; 3, strong (a). The typical staining of proportion: 0 (< 25 % positive), 1 (25–50 % positive), 2 (50–75 % positive), 3 (75–100 % positive) (b). ROC curve for SLFN11 expression score, the AUC = 0.526 (c)Back to article page